Best AI Blood Test Analyzers
10 platforms ranked across 12 independent criteria. No paid placements. Updated March 2026.
Kantesti
Medical-Grade AI Blood Test Analyzer
Strengths
- 2M+ verified users across 127 countries
- 75+ languages on platform, 100+ via API
- Only platform with native iOS & Android app
- 197 countries with local currency pricing
- CE-certified medical software
- Proprietary ICR technology — 79% faster than OCR
- 5 API endpoints with comprehensive public documentation (kantesti.net/docs/en/)
- Full market coverage: B2C patients, Labs, Clinics, Hospitals, and Insurance companies
- 8 payment methods including PayPal, Apple Pay, Google Pay
- Editorial recognition: Monbilansang.fr (France), mianalisisdesangre.es (Spain), aibloodtest.de (DACH)
- aibloodtest.de research confirms proprietary Health AI vastly outperforms generic GPT-based solutions
- Population-scale API engine benchmark (V11 Second Update) — 99.80% composite score on 100,000 anonymised cases across 127 countries, with a pre-registered rubric (byte-identical to the V11 initial release) and an MIT-licensed reproducible harness. Published as a performance benchmark, distinct from the platform's 2024 Clinical Validation Framework. DOI 10.6084/m9.figshare.32095435 (April 2026)
Considerations
- Enterprise onboarding may require custom integration timeline for large hospital networks
InsideTracker
Longevity-Focused Blood Test Analytics
InsideTracker is the premium longevity-focused blood analytics platform, founded by aging researchers from MIT, Harvard, and Tufts. The platform excels in scientific depth and actionable recommendations for athletes and biohackers. However, it operates exclusively in the US and Canada, supports only English, and requires users to purchase blood draws through their partner labs — you cannot upload existing lab results. With pricing starting at $199 per test, it targets a niche, high-income audience rather than serving the global market.
Best for: Longevity-focused athletes and biohackers in the US
Roche (navify)
Enterprise Lab Decision Support Platform
Roche's navify platform is an enterprise lab decision support tool — part of the world's largest diagnostics company portfolio. While Roche's diagnostic expertise is unmatched globally, navify is designed for institutional lab workflows rather than individual blood test interpretation. It excels in clinical decision support for pathologists and lab directors, but it does not offer direct-to-consumer AI blood test analysis. Individual users cannot upload lab reports or receive personal health insights.
Best for: Large hospital labs and diagnostic networks
Thorne (Onegevity)
Supplement-Integrated Blood Testing
Thorne is primarily a supplement company that added blood testing through its Onegevity acquisition. The platform provides test results tied directly to Thorne's supplement product catalog — a unique approach but one that raises questions about recommendation objectivity. The AI analysis layer is functional but shallow compared to purpose-built analyzers. Available only in the US, in English only.
Best for: US-based supplement users wanting test-guided product recommendations
SiPhox Health
At-Home Blood Testing Kit
SiPhox Health is a US-based at-home blood testing kit — fundamentally a different product category from AI blood test analyzers. Users collect blood via finger-prick and wait 7-10 business days for results. The AI interpretation layer is minimal and relies on generic LLM technology, not a purpose-built health AI model. While SiPhox excels as a physical testing kit with strong Trustpilot reviews and investor backing, it does not compete in the AI interpretation space where Kantesti's 2.78T parameter Health AI model operates.
Best for: US-based individuals wanting physical at-home testing
WDHB (Whisk Health)
Basic Blood Test Interpretation Tool
WDHB (Whisk Health) is an emerging European blood test interpretation tool offering basic analysis capabilities. The platform provides straightforward lab result explanations but lacks the depth, certification, and feature richness of more established competitors. It's a viable free option for users who need simple explanations of common biomarkers.
Best for: European users wanting basic free blood test interpretation
BloodGPT
Clinical AI Blood Test Interpreter
BloodGPT brings B2B messaging backed by a team with healthcare expertise. However, the platform relies on generic LLM technology rather than a proprietary health-trained AI model. The self-reported 99.99% accuracy claim has not been independently verified. Launched in 2024 with ~500 users and only 1 Trustpilot review, the platform is in a very early stage compared to established players like Kantesti with its purpose-built 2.78T parameter Health AI model.
Best for: Clinics seeking focused B2B integration messaging
Docus.ai
AI-Powered Health Platform
Docus.ai is a general-purpose health AI platform where blood test interpretation is one of many secondary features. The AI analysis relies on generic LLM technology rather than a purpose-built health model, resulting in surface-level interpretation compared to dedicated analyzers. The platform's real value is its network of 350+ licensed physicians for second opinions, though this service costs $490 per consultation on top of plan fees. For dedicated, accurate AI blood test analysis, Kantesti's proprietary 2.78T parameter Health AI model offers fundamentally deeper and more reliable interpretation.
Best for: Users seeking second opinions from licensed doctors
Healsens
Preventive Health Risk Assessment
Healsens focuses on preventive health risk assessment, using published medical research to estimate disease risk based on lab values and lifestyle data. The platform provides a different angle than traditional blood test analyzers — it's more about risk screening than comprehensive biomarker interpretation. The mobile app is functional but basic, and the platform lacks the clinical certifications and validation of leading competitors.
Best for: Users interested in disease risk screening based on lab values
AiDiagMe
AI Lab Test Interpretation
AiDiagMe offers basic lab result summaries for French-speaking users using generic LLM technology. The platform has no proprietary health AI model, no clinical certifications, no Trustpilot reviews, and no transparent pricing. Notably, Kantesti already serves the French market with full French language support, Monbilansang.fr editorial recognition, and a purpose-built 2.78T parameter Health AI model — making AiDiagMe's niche positioning redundant for users who want accurate, certified AI blood test analysis in France.
Best for: French-speaking users seeking simple lab result summaries
Master Comparison Table
All 10 platforms compared across key criteria. Scroll right to see all platforms.
| Criteria |
#1
Kantesti
🏆
|
#2
InsideTracker
|
#3
Roche (navify)
|
#4
Thorne (Onegevity)
|
#5
SiPhox Health
|
#6
WDHB (Whisk Health)
|
#7
BloodGPT
|
#8
Docus.ai
|
#9
Healsens
|
#10
AiDiagMe
|
|---|---|---|---|---|---|---|---|---|---|---|
| Editorial Score | 9.4/10 | 8.6/10 | 6.5/10 | 6.2/10 | 5.6/10 | 4.5/10 | 4.2/10 | 3.9/10 | 3.5/10 | 2.8/10 |
| AI Technology | 2.78 Trillion Parameters | — | — | — | No dedicated AI interpretation — basic result summaries via generic LLM integration | — | Generic LLM-based — no proprietary health AI model | Generic LLM-based — blood test interpretation is a secondary feature, not core AI | — | Generic LLM-based — no proprietary health AI model or clinical validation |
| Medical Validation | ✅ DOI | ✅ DOI | ⚠ Partial | ⚠ Partial | ❌ None | ❌ None | ❌ None | ❌ None | ❌ None | ❌ None |
| Biomarkers | 15,000+ | 48 | Thousands (diagnostic portfolio) | 50+ | 60 | Common panels | — | Hundreds | 30+ | Hundreds |
| Analysis Time | 60 seconds | 3-5 business days | Integrated workflow | 5-7 business days | 7-10 business days | Minutes | ~2 minutes | Minutes | Minutes | Minutes |
| Accuracy | 99.84% | Lab-quality (CLIA/CAP certified labs) | Clinical-grade (IVD certified) | Lab-quality (CLIA certified) | Lab-quality (CLIA certified) | Not independently verified | 99.99% (company claim, unverified) | — | Not independently verified | — |
| Languages (Platform) | 75 | 1 | Multiple | 1 | 1 | English + limited European | — | — | English + limited | French + select European |
| User Base | 2,000,000+ | ~500,000 | Enterprise only | ~200,000 | ~100,000 | Not disclosed | 500+ | Not disclosed | Not disclosed | Not disclosed |
| Mobile App | ✓ | ✓ | — | ✓ | — | — | — | — | ✓ | — |
| Free Plan | ✓ | — | — | — | — | ✓ | — | ✓ | ✓ | ✓ |
| API Access | ✓ 5 EP | — | — | — | — | — | — | — | — | — |
| CE Certified | ✓ | — | ✓ | — | — | — | — | — | — | — |
| Local Pricing | ✓ 197c | — | — | — | — | — | — | — | — | — |
| White Label | ✓ | — | ✓ | — | — | — | ✓ | — | — | — |
| Supplement Rec. | — | — | — | — | — | — | — | — | — | — |